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Abstract
Background: Disturbances in motor activity pattern are seen in both schizophrenia and depression. However, this 
activity has rarely been studied objectively. The purpose of the present study has been to study the complexity of 
motor activity patterns in these patients by using actigraphy.
Findings: Motor activity was recorded using wrist-worn actigraphs for periods of 2 weeks in patients with 
schizophrenia and major depression and compare them to healthy controls. Average motor activity was recorded and 
three non-parametric variables, interdaily stability (IS), intradaily variability (IV), and relative amplitude (RA) were 
calculated on the basis of these data. The motor activity was significantly lower both in patients with schizophrenia 
(153 ± 61, mean ± SD, p < 0.001) and depression (187 ± 84, p < 0.001), compared to controls (286 ± 80). The 
schizophrenic patients had higher IS and lower IV than the controls reflecting a more structured behavioural pattern. 
This pattern was particularly obvious in schizophrenic patients treated with clozapine and was not found in depressed 
patients.
Conclusions: Motor activity was significantly reduced in both schizophrenic and depressed patients. However, 
schizophrenic patients differed from both depressed patients and controls, demonstrating motor activity patterns 
marked by less complexity and more structured behaviour. These findings may indicate that disturbances in motor 
activity reflect different pathophysiological mechanisms in schizophrenia compared to major depression.
Findings
Assessing motor activity is essential in every psychiatric
evaluation. Despite this, objective methods are rarely
used in psychiatric clinical practice.
It is well known that increased or decreased gross
motor activity is often seen in patients with schizophre-
nia [1]. Altered motor activity is also an integral part of
the clinical picture of depressive states [2], and is seen in
seasonal affective disorder [3] and major depression in
children and adolescents [4]. Depressed patients differ
from normal and psychiatric comparison groups with
regard to objectively quantified gross motor activity, body
movements, speech, and motor reaction time [5]. Psycho-
motor retardation during depression may be measured by
actigraph [2]. In major depressive disorder hypofrontality
and negative symptoms are related [6]. Total motor activ-
ity of patients with schizophrenia recorded by actigraphy
has been found positively correlated with structural brain
correlates (volume of left anterior cingulate cortex) [7],
and quantity of movement has also been related to nega-
tive symptoms. However, no correlation between the
motor symptoms of the Positive and Negative Syndrome
Scale (PANSS) and the actigraphy results has been
reported [8].
Circadian rhythm desynchronization may play a key
role in mood disorders, and a therapeutic goal in treating
depression and other mood disorders is to restore normal
circadian rhythms. Actigraphy is more reliable than sleep
logs in the study of sleep and circadian rhythms [9]. In
schizophrenia possible circadian rest-activity rhythm dis-
turbances have not yet been widely studied.
In a study of schizophrenia by Wirz-Justice and col-
leagues [10] patients treated with clozapine had remark-
ably highly ordered rest/activity cycles, whereas the
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Page 2 of 7patients on classical neuroleptics had minor to major cir-
cadian rhythm abnormalities. This was the first docu-
mentation of circadian rest-activity cycle disturbances in
schizophrenia related to class of drug.
The diagnosis and classification of Schizophrenia and
Mood disorders are based on the fulfilment of symptom-
atic criteria, defined by the International Classification of
Disease (ICD) and DSM-IV respectively, and in both
cases diagnoses consists of a combination of traits and/or
symptoms defining a very broad syndrome. In both disor-
ders diagnoses are characteristically based on the
patient's description of symptoms and objective, quanti-
tative findings would be particularly helpful in the diag-
nosis of these disorders.
Our aim was to explore the usefulness of objective
recording of motor activity to reveal disturbances in the
pattern of motor activity in schizophrenia and major
depressive disorder, as this could reflect differences in the
underlying pathophysiological mechanisms of these dis-
orders.
Methods
Subjects
The study group consisted of 23 open ward long-term
patients with schizophrenia, and 23 currently depressed
patients, five of those inpatients (28%). Characteristics of
the patients with schizophrenia are shown in Table 1, and
with major depression in Table 2.
Control subjects were hospital employees (n = 23), stu-
dents (n = 5), and patients without serious medical or
psychiatric symptoms from a primary care office (n = 4).
The control group comprised 20 women and 12 men,
average age 38.2 ± 13.0 years (mean ± SD), range 21 - 66.
None of the control subjects had a history of mood or
psychotic symptoms.
All the patients in the schizophrenia group were on
antipsychotics, adherence to medication confirmed by
therapeutic drug monitoring. Of these patients, eight
men and one woman were treated with clozapine, the
others with traditional and atypical antipsychotics (Table
3). The clozapine treated patients were slightly younger
(43.3 vs. 48.9 years, p < .05), and had higher BPRS scores
(Table 1). The rationale for using clozapine was to
improve symptom control, both positive and negative
symptoms. Some of the clozapine patients had been
refractory to several alternative regimens. There was no
tendency of patients suffering from more pronounced
negative symptoms being treated with clozapine. All 23
patients have a chronic severe mental illness and were
considered unable to live independently.
Fifteen of the 23 patients with major depression were
on antidepressants, some co-medicated with lithium,
mood stabilizers, antipsychotics, anxiolytics or hypnot-
ics, while eight patients did not use psychotrophics.
Diagnostic Procedures
Diagnostic assessments of mood disorders were per-
formed by one of the authors (OBF), assessments of
schizophrenia were made by another author (JØB), based
on a semi-structured interview (SCID-I, section A: affec-
tive episodes, section B: psychotic and associated symp-
toms) and DSM-IV criteria (American Psychiatric
Association 1994) [11].
Evaluation of depressive and psychotic symptoms
In the depression group affective symptoms were
assessed by Montgomery-Asberg Depression Rating
Scale (MADRS) scores [12], and in the schizophrenia
group symptoms were assessed by the Brief Psychiatric
Rating Scale (BPRS) [13].
Recording of motor activity
Actigraphy is a quantitative method both to measure
gross motor activity, and to examine diurnal variations in
motor activity. In our study motor activity was monitored
Table 1: Demographic and clinical characteristics of patients with schizophrenia (n = 23).
Age (mean ± SD) 46.7 ± 10.9 (range 27 - 69)
Year at first hospitalization 24.4 ± 9.3 (range 10 - 52)
N %
Gender (male) 20 87
Diagnostic subtype
Paranoid 18 78
Non paranoid 5 22
BPRS 50.6 ± 8.9 (n = 18)
clozapine 55.0 ± 4.9 (n = 8)
not clozapine 47.0 ± 9.9 (n = 10)
p = 0.04 (t-test)
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Cambridge Neurotechnology Ltd, England). The right
wrist was chosen for the participant's convenience. Previ-
ous studies have shown small differences between the
right and left wrist [14-16]. Total activity counts were
recorded for one minute intervals for a continuous period
of two weeks. Both patients and controls were instructed
to wear their actigraphs at all times except when taking a
shower.
Mathematical analyses
The variables interdaily stability (IS), intradaily variability
(IV), and relative amplitude (RA), developed for analysis
of actigraph data, were used [17]. The IS quantifies the
invariability between the days, that is, the strength of
coupling of the rhythm to supposedly stable environmen-
tal factors. The IV indicates the fragmentation of the
rhythm, that is, the frequency and extent of transitions
between rest and activity. RA is calculated using data
from the most active 10 h period and the least active 5 h
period in the average 24 h pattern. IS, IV and RA were
calculated for the whole two week period.
Ethics
The study protocol was approved by the local ethics com-
mittee (REK III, Health -West, Norway).
Statistics
T-tests (two-tailed) were used to calculate differences
between groups, with a significance level of 0.05. SPSS
version 15.0 was used for the statistical analyses.
Results
Activity counts during 24 hours, calculated using one
hour intervals, for patients with major depression,
schizophrenia, and healthy controls are shown in Figure
1. Total and night time activity, as well as results from the
calculation of interdaily stability, intradaily variability,
and relative amplitude are shown in Table 4. Analyses of
variance (ANOVA) showed significant differences
between the groups for all these parameters, with the
exception of relative amplitude. Schizophrenic patients
and patients with depression both showed substantial
reductions in total activity (47% and 35% compared to the
control group), but the schizophrenic patients had a more
pronounced reduction in night time activity (57%) than
Table 2: Demographic and clinical characteristics of patients with a major depressive episode (n = 23).
Age (mean ± SD) 42.8 ± 11.0
Education (years ± SD) 11.5 ± 2.8
MADRS (start of registration, mean ± SD ) 22.7 ± 4.8
MADRS (end of registration, mean ± SD ) 20.0 ± 4.7
N %
Gender (male) 13 57
Married or cohabiting 11 48
Currently working 3 13
Diagnoses
Unipolar major depressive disorder 15 65
Bipolar I disorder 1 4
Bipolar II disorder 7 30
Table 3: Psychotropic drug treatment for patients with schizophrenia (n = 23).
N %
Clozapine 9 39
Other antipsychotics 14 61
Traditional antipsychotics 6 26
Atypical antipsychotics 8 35
Mood stabilizers 5 22
Clozapine dose 481 ± 218 mg (range 300 - 900)
Serum level of clozapine 1671 ± 1164 μmol/l (range 326 - 3333)
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bility was 18% higher in the schizophrenic patients com-
pared to controls, while the depressed patients showed
little difference (4% reduction). Intradaily variability was
18% lower in the schizophrenic patients and 8% lower in
the depressed patients, compared to controls. In the
depression group, no differences in the five parameters
were seen, comparing bipolar and unipolar patients (data
not shown).
All results in the control groups were similar for males
and females. We have therefore combined the results
from male and female participants. The schizophrenic
patients were mostly male (20/3), while in the control
group there were more females (20/12). When restricting
the ANOVA analyses to males only, differences between
the groups were still significant, for average activity (42%
reduction in the schizophrenic patients) and night time
activity (57% reduction in the schizophrenic patients).
Intradaily variability was 19% lower in the schizophrenic
patients compared to controls and interdaily stability was
12% higher, but the ANOVA analyses were not significant
for these parameters. Average age in the two groups was
different (46.7 vs. 38.2 years, p = 0.013), but when ana-
lyzed separately in the control and schizophrenic groups,
there was no significant correlations with age. The
depressed patients were not significantly different form
the controls in terms of gender distribution and age. We
found no significant correlations between either MADRS
or BPRS and the different actigraphy motor parameters.
The results from schizophrenic patients treated with
clozapine, compared to those treated with other antipsy-
chotics are shown in Table 5. There were similar reduc-
tions in activity counts in the two patient groups (46%
and 47%), but the clozapine group had a more pro-
nounced reduction in night time activity (73% vs. 47%).
Only the clozapine group showed significant increased
interdaily stability (38%) and reduced intradaily variabil-
ity (24%). In the clozapine group the serum level of clo-
zapine did not correlate with motor activity.
As 18 of the 23 patients diagnosed with schizophrenia
had the paranoid subtype, the other subgroups were too
small for meaningful comparisons.
Discussion
We found clear differences in motor activity between the
three groups we have studied. However more interest-
ingly, we found differences between patients and con-
trols, and also between patients with schizophrenia and
depression, using the two non-parametric variables inter-
daily stability (IS) and intradaily variability (IV), intro-
duced by Van Someren et al [17]. The interdaily stability
(IS) reflects the 24 hour rhythm component; a low value
indicates reduced variability between days. The intradaily
variability (IV) assesses the fragmentation of the rhythm;
a low value indicates less fragmentation or more struc-
ture of the rhythm. A more structured rhythm was found
in schizophrenic patients. This may reflect a more struc-
tured or monotonous behavioural pattern. Our findings
of increased interdaily stability and the reduced intradaily
variability in the schizophrenic patients are compatible
with this. This pattern is not seen in the depressed
patients even if they have a similarly reduced activity
level.
To the best of our knowledge, this is the first study
based on actigraphy to address differences in motor activ-
ity pattern between patients with schizophrenia and
patients with depression.
The activity levels were reduced to the same extent in
depressed and in schizophrenic patients, when compared
to healthy controls. The marked alteration in motor activ-
ity between the schizophrenic patients and the controls
[1], and reduced activity in depressed patients, is in
agreement with previous studies [2,18-20]. One study
reports a lower motor activity level and a reduced frag-
mentation of motor activity during wake in unmedicated
depressed inpatients [21]. The lower motor activity
reported by Volkers [21], is in agreement with our current
findings. Volkers et al [22] also reports an increase in
motor activity after treatment with imipramine. We do
not have comparable data. Volkers et al [21] also reported
increased motor activity during sleep. We were not able
to replicate this. According to our study, a lower motor
activity level was seen in depressed patients at night,
although not significantly so. A reduced fragmentation of
the rhythm during daytime as reported by Volkers [21] is
Table 4: Actigraphic recordings in patients with schizophrenia and depression, compared to controls.
Control Schizophrenia Depression ANOVA
Total activity (00 - 24) 286 ± 80 153 ± 61*** 187 ± 84 *** F(75,2) = 22.965, P < 0.001
Activity night (23 - 06) 89 ± 53 38 ± 32 *** 61 ± 33 F(75,2) = 10.162, P < 0.001
Interdaily stability 0.446 ± 0.113 0.526 ± 0.154 0.428 ± 0.129 F(75,2)= 3.722, P = 0.029
Intradaily variability 0.901 ± 0.168 0.742 ± 0.190 0.825 ± 0.282 F(75,2)= 3.714, P = 0.029
Relative amplitude 0.837 ± 0.118 0.801 ± 0.141 0.836 ± 0.121 F(75,2)= 0.657, P = 0.521
t-test, *** p < 0.001; schizophrenia or depression compared to the control group
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the mathematical methods used in these two studies. Psy-
chomotor symptoms may be more pronounced in bipolar
patients [23], but we were not able to find any differences
between bipolar and unipolar patients in our sample.
It has recently been demonstrated that objectively mea-
sured motor activity by actigraphy is inversely related to
clinically assessed negatives symptoms in schizophrenia
[8]. The low motor activity level found in patients with
schizophrenia may reflect this.
Marked alterations in motor activity in depressed
patients are usually associated with melancholic depres-
sion [24]. The diagnostic category melancholic depres-
sion can overlap with other diagnostic categories like
unipolar depression or bipolar I disorder.
However, reduced motor activity may be a more gen-
eral feature in major depression as only one of our
patients had a melancholic depression.
Motor impairment in depression and in schizophrenia
has been linked to the bradykinesia of Parkinson's dis-
ease, implying altered dopaminergic function, involving
the nigrostriatal system [20]. The tremor of Parkinson's
disease, loss of facial mobility, and walking pattern, all
indicate a motor system operating in a more structured
or stereotype fashion [25].
Our findings therefore suggest that the schizophrenic
patients have a more severe disturbance of the motor
control system than the depressed patients, perhaps more
similar to that seen in Parkinson's disease.
Figure 1 Activity counts during 24 hours with one hour intervals (mean), and 6 hours intervals (mean ± SD).
Time (hours)
5 10 15 20
A
ct
iv
ity
 
co
u
n
t/h
ou
r
0
5000
10000
15000
20000
25000
30000
35000
Control
Depression
Schizophrenia
 
 
 
                             Control          Depression    Schizophrenia        ANOVA
  
 
Night       (00 – 06)  14799  ± 14120     12687  ± 12219     12062  ±  24397       F(75,2)=  0.184,  P=0.832 
 
Morning     (06 – 12)       119528  ± 67931      74223  ± 47835*   67122  ± 38962**    F(75,2)=  7.274,  P=0.001   
 
Afternoon   (12 – 18)       164809 ± 56828   112324  ± 70084** 84698  ± 37253***  F(75,2)=13.857,  P<0.001 
 
Early night  (18 – 24)      118102 ± 56573     75582  ± 50833** 48985  ± 26322***  F(75,2)=14.119,  P<0.001 
 
t-test : * p < 0.017, ** p < 0.01, *** p <0.001; schizophrenia or depression compared to the control group 
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can better be understood as a dynamic reordering instead
of a disordering process resulting in a presentation char-
acterized by loss of complexity and development of ste-
reotypy, such as seen in Parkinson's disease [25,26]. We
hypothesize that similar long-term actigraphic recordings
in patients with Parkinson's disease may give results com-
parable to that seen in our schizophrenic patients.
The schizophrenic patients showed an activity pattern
characterized both by low total activity and lower night-
time activity, and in addition a more regular rest-activity
cycle, different from both controls and from the patients
with depression. In agreement with the study of Wirtz-
Justice, Haug and Cajochen from 2001 [10], we found the
most marked differences on motor activity in the patients
treated with clozapine. These patients are from the same
setting as the patients treated with other antipsychotics,
expecting the same external Zeit-gebers. Zeit-gebers
means environmental agents or events that provide the
cue for setting or resetting a biological clock, daylight or
social factors are examples of common Zeit-gebers to
help us get synchronized with our environment. It is
therefore reasonable to suppose that differences between
the groups must be caused either by intrinsic biological
differences or by the difference in drug treatment. The
controls in our study were employed and working, while
the patients were not. Obviously this is a potential source
of bias that might contribute to increased values of motor
activity in the controls. In the schizophrenia group, all
were in-patients in a psychiatric institution, although
some of those were living quite independent with their
individual daily routines including preparing their own
meals within such frames. One limitation of this study is
that the interdaily stability for the majority of patients in
the schizophrenia group may be under influence of the
institutional schedules like meals, although the difference
between clozapine treated schizophrenic patients and
schizophrenic patients treated with other antipsychotics
can not be explained this way.
One limitation of our study is the non-blind assessment
of diagnoses. However, the methods of investigating the
motor activity did not require a subjective evaluation.
Our long-term patients with schizophrenia, although in a
stable phase, all have a chronic severe mental illness and
they may not be representative for the whole diagnostic
group. At the other end of the spectrum our patients with
depression are mostly out-patients and may represent a
group with only low or intermediate severity of illness, as
indicated by the MADRS scores. These results require
replication in larger samples. We have not done a system-
atic assessment of adverse events, including neurological
side effect of motoric type (akathisia, parkinsonism etc)
in our patient groups [27]. Therefore, a limitation of our
study is the possible motoric side effects in the schizo-
phrenia group, particularly those not being treated with
clozapine.
Patients and control persons wore the actigraph on the
right hand. The rationale for this was that most people
have their wrist watch on their left hand and we thought
it would be inconvenient to have two such devices on the
same arm for an extended period of 2 weeks. It is of
course possible that this may have influenced the results,
and inflated the difference between the controls, which
were employed and working, and the patient groups. On
the other hand, previous studies have shown only small
differences between actigraph recordings from the right
and left arms [16].
An obvious strength of this study is the long recording
period, two weeks both for patients and healthy controls,
making observations of rhythms richer and enhancing
the detection of more nuanced and subtle changes in the
groups studied. The few existing actigraph studies of
patients with mental illness usually have shorter record-
ing periods, typically 24 to 48 hours. A further strength is
the recording of antipsychotic medication serum level of
all patients with schizophrenia, confirming their adher-
ence to the medication.
Conclusions
The pattern of motor activity in schizophrenic patients is
marked by less complexity, a finding different from con-
trols and patients with depression, and this finding may
Table 5: Actigraphic recordings in schizophrenic patients treated with clozapine or with other antipsychotics, compared 
to controls.
Control Clozapine Other antipsychotics ANOVA
Activity 286 ± 80 155 ± 54 *** 152 ± 67 *** F(51,2) = 22.127, P < 0.001
Activity night 89 ± 53 24 ± 10 *** 47 ± 38 F(51,2) = 8.887, P < 0.001
Interdaily stability 0.446 ± 0.113 0.616 ± 0.166 ** 0.468 ± 0.119 F(51,2) = 7.136, P = 0.002
Intradaily variability 0.901 ± 0.168 0.685 ± 0.223 ** 0.778 ± 0.163 F(51,2) = 5.898, P = 0.005
Relative amplitude 0.837 ± 0.118 0.875 ± 0.061 0.753 ± 0.158 F(51,2) = 4.317, P = 0.019
t-test, ** p < 0.01, *** p = 0.001 or <0.001; clozapine or other antipsychotics compared to the control group
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The difference in motor activity complexity could reflect
that motor activity derangements in schizophrenia and
depression have different foundations. Our work is one of
the few examples describing objective registration of clin-
ical symptoms and signs in patients with psychiatric ill-
ness. This methodology may prove useful in future
studies, allowing improved symptom description and a
better understanding of the complexity of these mental
illnesses, in particular regarding treatment with medica-
tion.
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